In a prior study, a different iteration of the LVOne GFAP LFA, employing a marginally higher threshold of GFAP (0.213 ng/ml) to indicate a positive test result, was used to assess plasma GFAP concentration in patients with suspected stroke. This evidence concerns the gene GFAP and Stroke.